These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 856307)

  • 1. [Effect of kininogen on the activity of human blood serum kininogenase system].
    Datsenko VL; Iarovaia GA; Golosova NA; Lebedeva NV; Orekhovich VN
    Biokhimiia; 1977 Feb; 42(2):283-6. PubMed ID: 856307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of kininogen on the activity of the kallikreinogen-kallikrein system of human blood serum.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1977 Jul; 78(1):85-9. PubMed ID: 884851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification and enzyme study of kininogens I and II from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):248-53. PubMed ID: 1032268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seasonal fluctuations in the kallikrein-kinin system indices].
    Tokaeva LK; Tsareva TD
    Vopr Med Khim; 1979; 25(3):266-8. PubMed ID: 222069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of components of the kallikrein-kinin system in the arterial and venous blood and cerebrospinal fluid of patients with severe cranio-cerebral injuries].
    Valeev IK; Raĭzman SM; Tsibul'kin AP
    Zh Vopr Neirokhir Im N N Burdenko; 1979; (1):27-30. PubMed ID: 425774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
    Nartikova VF; Egorova TP; Rets EV; Paskhina TS
    Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification and properties of high-molecular-weight rabbit kininogen].
    Egorova TP; Rossinskaia EB; Paskhina TS
    Biokhimiia; 1976 Jul; 41(6):1052-60. PubMed ID: 1027487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of kininogenesis indices].
    Surovikina MS; Maslikova GV; Fomina EE
    Biull Eksp Biol Med; 1983 May; 95(5):106-9. PubMed ID: 6552200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
    Silverberg M; Longo J; Kaplan AP
    J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surfaces on fluid-phase prekallikrein activation.
    Scott CF; Kirby EP; Schick PK; Colman RW
    Blood; 1981 Mar; 57(3):553-60. PubMed ID: 6906235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.
    Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the blood kinin system in the pathogenesis of the hemorrhagic syndrome in hemorrhagic vasculitis].
    Bleian GT; Pogosian AS; Stepanian MA; Osipova EN
    Vopr Med Khim; 1978; 24(6):779-81. PubMed ID: 734977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [State of the kinin system in burn shock and early toxemia].
    Paskhina TS; Nartikova VF; Dotsenko VL; Maslova TM; Morozova NA
    Vopr Med Khim; 1976; 22(5):696-707. PubMed ID: 1014484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.